Advanced Enzyme Technologies quarterly results and financials

Advanced Enzyme Technologies (ADVENZYMES)₹282.10−0.74%(9 Nov 2026 close)Biotechnology

Key facts

In the Jun 2026 quarter (consolidated), Advanced Enzyme Technologies reported sales of ₹190 Cr, up 2.1% from Jun 2025, and net profit of ₹38.95 Cr, down 2.4% year on year. For the year to Mar 2026, sales were ₹746 Cr and net profit ₹174 Cr.

Sales (Jun 2026): ₹190 Cr
Net profit (Jun 2026): ₹38.95 Cr
Sales (FY Mar 2026): ₹746 Cr
Net profit (FY Mar 2026): ₹174 Cr
EPS (Jun 2026): ₹3.32
Borrowings (Mar 2026): ₹32.09 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Advanced Enzyme Technologies quarterly results

₹ crore unless stated; each column is a quarter.

Advanced Enzyme Technologies Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	158	161	158	155	146	169	167	186	185	172	203	190
Expenses	107	107	102	103	104	114	122	129	124	123	140	139
Operating Profit	50.94	54.01	54.94	50.96	41.96	54.97	45.95	55.98	59.97	49.01	62.94	50.96
OPM %	32.0%	33.0%	35.0%	33.0%	29.0%	33.0%	27.0%	30.0%	33.0%	29.0%	31.0%	27.0%
Other Income	6.02	14.04	−6.02	7.03	10.04	8.03	9.03	9.04	10.03	20.08	7.02	13.05
Interest	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01
Depreciation	8.97	8.96	8.96	8.97	8.97	8.97	9.97	9.97	9.97	9.96	9.96	9.96
Profit before tax	48.04	59.11	40.08	49.10	42.09	53.05	43.04	55.10	60.11	58.12	60.12	54.07
Tax %	27.0%	28.0%	25.0%	28.1%	21.0%	27.1%	38.0%	26.0%	25.1%	26.0%	24.1%	28.1%
Exceptional items	0.00	0.00	−10.13	0.00	0.00	0.00	0.00	0.00	0.00	8.34	0.10	0.00
Net Profit	34.97	41.96	29.97	34.96	32.95	38.93	26.97	39.92	44.91	42.94	44.92	38.95
EPS (Rs)	3.07	3.73	2.52	3.06	2.95	3.38	2.36	3.58	3.86	3.79	3.83	3.32

Advanced Enzyme Technologies profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Advanced Enzyme Technologies Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	293	329	391	420	444	502	529	541	624	637	746	750
Expenses	155	176	225	235	240	268	326	381	417	440	513	525
Operating Profit	138	152	165	184	203	232	203	158	206	196	230	223
OPM %	47.0%	46.0%	42.0%	44.0%	46.0%	46.0%	38.0%	29.0%	33.0%	31.0%	31.0%	29.7%
Other Income	−3.01	3.01	1.01	5.01	6.02	9.03	6.02	21.07	21.09	33.13	46.14	50.18
Interest	8.02	4.01	9.02	5.01	4.01	3.01	3.01	3.01	4.01	5.01	4.01	4.04
Depreciation	8.97	12.97	17.94	20.92	25.90	27.89	34.91	34.89	34.86	36.89	39.84	39.85
Profit before tax	118	137	139	162	179	210	171	140	188	187	233	232
Tax %	35.0%	32.1%	33.0%	28.0%	26.1%	28.0%	28.0%	26.0%	27.0%	28.0%	25.1%	—
Exceptional items	−3.01	0.00	0.00	0.00	0.00	1.01	1.01	−3.01	−11.02	0.00	14.03	8.44
Net Profit	76.84	92.89	93.94	116	133	151	124	104	137	134	174	172
EPS (Rs)	6.96	8.19	8.06	9.96	11.59	13.08	10.71	9.46	11.91	11.71	15.06	14.80
Dividend payout %	3.0%	5.0%	6.0%	6.0%	5.0%	7.0%	9.0%	11.0%	43.0%	44.0%	35.9%	—

Advanced Enzyme Technologies balance sheet

₹ crore, at each year end.

Advanced Enzyme Technologies Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	22.09	22.10	22.09	22.10	22.10	22.09	22.10	22.09	22.09	22.09	22.09	22.09
Reserves	189	257	443	539	659	819	951	1,069	1,215	1,304	1,400	1,611
Borrowings	115	101	54.20	67.26	35.13	28.10	23.09	35.15	34.10	47.17	39.14	32.09
Other Liabilities	92.44	71.33	65.31	102	91.43	105	154	138	143	151	152	171
Total Liabilities	419	452	585	729	807	974	1,150	1,264	1,413	1,524	1,614	1,836
Fixed Assets	288	286	422	492	497	565	603	622	651	652	682	694
CWIP	5.01	7.01	8.01	10.99	9.99	9.99	9.99	14.99	21.99	40.98	22.01	50.96
Investments	0.00	0.00	0.00	0.00	111	124	121	102	359	402	479	583
Other Assets	125	159	154	227	189	276	415	526	382	429	432	509
Inventories	53.12	60.12	68.12	76.14	77.10	80.11	94.14	121	124	148	157	177
Trade receivables	37.08	42.06	50.05	59.05	59.07	75.05	86.18	88.19	100	99.19	115	145
Cash & equivalents	4.01	26.03	8.01	61.06	23.03	83.10	198	275	123	127	108	116
Total Assets	419	452	585	729	807	974	1,150	1,264	1,413	1,524	1,614	1,836

Advanced Enzyme Technologies cash flow

₹ crore, for each year.

Advanced Enzyme Technologies Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	53.95	92.79	107	116	129	141	163	122	140	141	142	157
Cash from investing activity	−14.99	−9.99	−59.91	−59.93	−124	−42.96	−26.98	1.99	−286	−64.92	−88.98	−71.93
Cash from financing activity	−35.92	−62.85	−64.84	−1.99	−42.85	−38.89	−25.93	−47.87	−25.91	−58.82	−72.80	−69.80
Net cash flow	2.01	21.10	−18.07	54.17	−38.13	60.26	109	75.28	−172	17.07	−20.07	15.05
Capex	12.95	4.98	9.96	10.95	11.96	50.80	19.91	27.87	37.84	46.81	34.88	51.78
Free cash flow	41.85	87.73	96.64	105	116	89.69	142	94.66	102	93.61	108	105
CFO / OP %	87.9%	88.0%	104.9%	97.0%	70.0%	93.9%	94.0%	87.0%	112.0%	92.9%	102.9%	95.9%

Advanced Enzyme Technologies ratios

Working-capital days and returns, by year.

Advanced Enzyme Technologies Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	61	52	55	55	51	61	63	61	68	58	66	71
Inventory days	402	357	351	338	362	360	345	401	342	374	377	334
Days payable	88	67	56	77	45	42	55	59	66	39	46	75
Cash conversion cycle	373	341	350	314	368	378	352	403	343	392	396	330
Working capital days	−42	4	77	48	73	91	95	117	110	103	113	117
ROCE %	24.9%	36.0%	31.0%	24.9%	24.0%	22.0%	22.0%	16.0%	12.0%	15.0%	12.9%	14.0%

Advanced Enzyme Technologies: frequently asked questions

What are the latest quarterly results of Advanced Enzyme Technologies?

For the Jun 2026 quarter, Advanced Enzyme Technologies reported sales of ₹190 Cr, up 2.1% year on year and net profit of ₹38.95 Cr, down 2.4% year on year. The operating margin was 27.0%.

What is the annual revenue of Advanced Enzyme Technologies?

Advanced Enzyme Technologies' sales for the year to Mar 2026 were ₹746 Cr; over the last twelve months they were ₹750 Cr.

What is the net profit of Advanced Enzyme Technologies?

Net profit for the year to Mar 2026 was ₹174 Cr, and ₹172 Cr over the last twelve months. Earnings per share over the same trailing period were ₹14.80.

How much debt does Advanced Enzyme Technologies have?

Advanced Enzyme Technologies reported borrowings of ₹32.09 Cr at Mar 2026, against cash and equivalents of ₹116 Cr.

What is the free cash flow of Advanced Enzyme Technologies?

Cash from operations was ₹157 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹105 Cr.

Loading…